benralizumab
Sponsor Astrazeneca PLC · listed as AZN
benralizumab is a drug asset sponsored by Astrazeneca PLC, listed as AZN. CSA tracks 2 forward catalysts for it — the nearest is a readout expected Dec 23, 2026 (day precision, medium confidence), tied to trial NCT05692180. That trial is in Phase 3 and currently active not recruiting, studying Asthma. It appears across 4 tracked trials in the CSA sample.
Next catalyst
Trial & sponsor
All tracked catalysts for benralizumab
| Date | Event | Confidence | Trial |
|---|---|---|---|
| 2026-12-23 | READOUT | medium | NCT05692180 |
| 2028-02-20 | READOUT | medium | NCT06512883 |
Trials for benralizumab in the CSA sample
| Trial | Phase | Status | Primary completion | Role | Lead sponsor | Condition(s) |
|---|---|---|---|---|---|---|
| NCT04157348 | Phase 3 | Active, not recruiting | 2023-08-10 | Experimental | AstraZeneca | Eosinophilic Granulomatous Vasculitis |
| NCT05692180 catalyst | Phase 3 | Active, not recruiting | 2026-12-23 | Experimental | AstraZeneca | Asthma |
| NCT06512883 catalyst | Phase 3 | Recruiting | 2028-02-20 | Experimental | AstraZeneca | Eosinophilic Granulomatosis With Polyangiitis (EGPA); Hypereosinophilia Syndrome (HES) |
| NCT07444567 | Phase 3 | Recruiting | 2029-12-27 | Experimental | AstraZeneca | Asthma; Eosinophilic Granulomatosis With Polyangiitis (EGPA); Hypereosinophilic Syndrome (… |
Each trial links to its ClinicalTrials.gov record; primary completion dates are as registered there.
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This page is one record from the free CSA sample. The full snapshot covers active, industry-sponsored Phase 3 trials in cardiometabolic, oncology and immunology. Every forward catalyst carries its date, confidence grade and source link, and is linked to its sponsor's ticker when the sponsor is a listed company.
Get the full dataset — $499 → More AZN catalysts